跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 893 条关于
“CF PharmTech”
全部
893
临床试验
473
药物
90
机构
219
资讯
111
6个月前
CF PharmTech Receives NMPA Acceptance for First-in-Class Inhaled Pulmonary Fibrosis Treatment ICF004
去年
Cystic Fibrosis Foundation Invests $15 Million in Recode Therapeutics for CF Gene Editing
去年
Trikafta Significantly Reduces Lung Transplants in Cystic Fibrosis Patients
去年
Eplontersen (Wainzua) Recommended in England and Wales for Hereditary Transthyretin Amyloidosis
去年
FDA Approves AbbVie's Vyalev for Advanced Parkinson's Disease
去年
EMA Recommends 114 Drugs for Approval in 2024, Addressing Key Public Health Needs
去年
Trikafta Expansion Celebrated as Major Breakthrough for Cystic Fibrosis Patients
去年
Spirovant Sciences Doses First Patient in Phase 1/2 Trial of SP-101 Gene Therapy for Cystic Fibrosis
去年
Clarametyx Advances CMTX-101 into Phase 2a for Cystic Fibrosis Lung Infections
去年
Arcturus Therapeutics Initiates Phase 2 Trials for mRNA Therapies Targeting Cystic Fibrosis and OTC Deficiency
第 1 页,共 12 页
上一页
下一页